Medical & Pharmacy Policy Update

Blue Cross and Blue Shield of Kansas (BCBSKS) has published the following updated medical policies on the BCBSKS Website. Click on a link to view the details of each policy.

Published 07/01/22:

Artificial Intervertebral Disc: Cervical Spine
Artificial Intervertebral Disc: Lumbar Spine
Ambulatory Event Monitors and Mobile Cardiac Outpatient Telemetry
Wearable Cardioverter Defibrillators
Catheter Ablation as Treatment for Atrial Fibrillation
Implanted Peripheral Nerve Stimulator (PNS) for Pain Control
Immunoglobulin Therapy

Pharmacy Policies:

IL-13 antagonist
Insulin Pump
Factor VIII and VW Factor
Lupus

Many of our pharmacy medical policies are maintained through our pharmacy benefit manager, Prime Therapeutics.

To find pharmacy medical policies specific to a medication list, please select a medication list at the bottom of our prior authorization page of our website, https://www.bcbsks.com/providers/precertification-prior-authorization.

The following Medical Policies had new codes effective 07/01/22:

Bio-Engineered Skin and Soft Tissue Substitutes
Cochlear Implant
Corneal Collagen Cross-Linking
Continuous Glucose Monitoring
Interspinous and Interlaminar Stabilization / Distraction Devices (Spacers)
Optical Coherence Tomography (OCT) of the Anterior Eye Segment
Orthopedic Applications of Stem Cell Therapy (Including Allograft and Bone Substitute Products Used With Autologous Bone Marrow)
Positron Emission Tomography (PET) Scanning: Oncologic Applications

If you have questions regarding this publication, please contact your BCBSKS provider consultant/representative.

Institutional Providers
Professional Providers